Remove Clinical Trials Remove Development Remove Regulation Remove Research Analyst
article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

COVID-19 Vaccine Data Not Expected Until November as FDA Releases Guidelines for Emergency Use Authorizations

XTalks

The US FDA also outlined advice to developers looking to get emergency use authorizations (EUA) in a guidance document that it released last week. As part of its efforts, the agency has plans to conduct a meeting for independent experts to review overall progress on coronavirus vaccine development.